The 29 rating InvestorsObserver gives to Neurosense Therapeutics Ltd (NRSN) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 71 percent of stocks in the Healthcare sector, NRSN’s 29 overall rating means the stock scores better than 29 of all stocks.
NRSN has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on NRSN!